Entries by Michael Kuhrt

French Valneva appoints new CMO

In October Juan Carlos Jaramillo will take over the business from Wolfgang Bender as new Chief Medical Officer and member of the Valneva Management Board.

Protection in case of SPCs for pharmaceuticals?

SPCs offer up to five and a half years of additional protection after patent expiration for pharmaceuticals in order to compensate the patent holder’s inability to exploit their inventions while products undergo lengthy regulatory approvals.

Rentschler Biopharma expands U.S. footprint

Prior to Danish Genmab A/S’s recent licence option deal with AbbVie Inc, Rentschler Biopharma has extended its collaboration with Genmab. European Biotechnology spoke with Rentschler Biopharma SE’s SVP Global BD Federico Pollano about the CDMO’s expertise in DuoBody® molecules production and the expansion of the CDMO’s U.S. production site in Milford.